Stay updated with breaking news from Doha Declaration. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A small number of pharmaceutical companies with the support of developed country governments invested billions of dollars in research and development of COVID-19 vaccines, related medicines, and technologies including mRNA, DNA, RNA, viral vector, protein subunit and testing materials along with their production and distribution.
Trade bodies are dictating access to COVID-19 drugs. But will patent waivers increase production in the global South?
To embed, copy and paste the code into your website or blog: Or maybe not. On April 30th, Ambassador Katherine Tai, U.S. Trade Representative (USTR), issued the 2021 Special 301 Report. In a press release, the USTR stated that "[i]ntellectual property rights incentivize our creators, manufacturers, and innovators to invent new products and technologies." The press release notes that the review period underlying the Report took place during the COVID-19 pandemic, "the largest global health crisis in more than a century." Consistent with recent decisions (including support for the propo...
The writer is a former SAPM Health. LIKE every crisis, the Covid-19 pandemic has also brought some opportunities, two in particular. First, it has spurred innovation. In relatively no time, experimental vaccines started queuing up. The mRNA-based vaccine was developed which is a watershed innovation. This is going to profoundly change the future of prevention and therapeutics. Regulatory pathways for emergency use authorisation for these vaccines have also worked well. Second, on May 5, the US announced support for the Covid-19 TRIPS waiver. This is also a major development. The director gene...
The AIDS fight offers a COVID vaccine patent pathway Updated: Updated: May 22, 2021 07:30 IST There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle Share Article AAA There are recognised ways to overcome the patents hurdle, ensuring social justice and boosting the COVID-19 battle In order to achieve global herd immunity and prevent new strains of COVID-19 from emerging, possibly for years to come, vaccines need to be affordable and available in massive quantities throughout the globe. This can happen through patent owners volunta...